We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$84.7B
AUM Growth
+$3.15B
Cap. Flow
-$3.2B
Cap. Flow %
-3.77%
Top 10 Hldgs %
10.93%
Holding
2,264
New
35
Increased
617
Reduced
853
Closed
525

Top Buys

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$128M
2
DHR icon
Danaher
DHR
+$114M
3
ZBRA icon
Zebra Technologies
ZBRA
+$112M
4
AIZ icon
Assurant
AIZ
+$92.7M
5
EXC icon
Exelon
EXC
+$92.2M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$189M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$143M
3
MRK icon
Merck
MRK
+$136M
4
ABMD
Abiomed Inc
ABMD
+$124M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$124M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Healthcare 15.17%
3 Financials 13.51%
4 Industrials 10.72%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DOUG icon
1801
Douglas Elliman
DOUG
$155M
– –
-1,716
Closed -$14K
DUOL icon
1802
Duolingo
DUOL
$5.7B
– –
-35,445
Closed -$3.38M
EAF icon
1803
GrafTech
EAF
$194M
– –
-495
Closed -$30K
EBS icon
1804
Emergent Biosolutions
EBS
$375M
– –
-465
Closed -$22K
EDIT icon
1805
Editas Medicine
EDIT
$399M
– –
-1,190
Closed -$24K
EGHT icon
1806
8x8 Inc
EGHT
$247M
– –
-4,737
Closed -$21K
EHAB
1807
DELISTED
Enhabit
EHAB
– –
-12,431
Closed -$187K
ENTA icon
1808
Enanta Pharmaceuticals
ENTA
$372M
– –
-178
Closed -$21K
ENSG icon
1809
The Ensign Group
ENSG
$10.1B
– –
-537
Closed -$119K
ENVA icon
1810
Enova International
ENVA
$5.91B
– –
-1,203
Closed -$63K
EPC icon
1811
Edgewell Personal Care
EPC
$1.27B
– –
-516
Closed -$29K
ESGR
1812
DELISTED
Enstar Group
ESGR
– –
-268
Closed -$84K
EVGO icon
1813
EVgo
EVGO
$200M
– –
-1,642,206
Closed -$13M
EVMT icon
1814
Invesco Electric Vehicle Metals Commodity Strategy No K-1 ETF
EVMT
$7.06M
– –
-300,000
Closed -$6.2M
EVRI
1815
DELISTED
Everi Holdings
EVRI
– –
-1,097
Closed -$36K
EVTC icon
1816
Evertec
EVTC
$1.83B
– –
-1,402
Closed -$65K
EXP icon
1817
Eagle Materials
EXP
$6.6B
– –
-417
Closed -$52.7K
AGNT
1818
AGNT Inc
AGNT
$664M
– –
-1,139
Closed -$26K
EXPO icon
1819
Exponent
EXPO
$2.98B
– –
-1,044
Closed -$151K
FATE icon
1820
Fate Therapeutics
FATE
$281M
– –
-636
Closed -$40K
FCEL icon
1821
FuelCell Energy
FCEL
$1.7B
– –
-381
Closed -$50K
FCFS icon
1822
FirstCash
FCFS
$8.55B
– –
-754
Closed -$90K
FDMT icon
1823
4D Molecular Therapeutics
FDMT
$526M
– –
-2,300
Closed -$18K
FFIN icon
1824
First Financial Bankshares
FFIN
$4.97B
– –
-1,350
Closed -$125K
KYNB
1825
Kyntra Bio
KYNB
$28.5M
– –
-66
Closed -$34K
71 72
73
74 75

Similar funds

AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return

Macquarie Group's Q4 2022 Portfolio in Review

As of Q4 2022, Macquarie Group held 2,264 positions worth $84.7B, up 3.9% from $81.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group withdrew a net $3.2B in Q4 2022, closing 525 positions and reducing 853 holdings. Its most notable exit was Abiomed Inc, an estimated $124M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in iShares 0-5 Year Investment Grade Corporate Bond ETF worth $58.3M.

  • Macquarie Group's largest Q4 2022 buy was iShares 0-5 Year Investment Grade Corporate Bond ETF: 1,218,670 shares worth $58.3M.
  • Macquarie Group added most to L3Harris in Q4 2022, an estimated $128M increase.
  • Macquarie Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $189M.
  • Macquarie Group fully exited Abiomed Inc in Q4 2022, selling an estimated $124M.
  • Macquarie Group's ten largest holdings make up 11% of its $84.7B portfolio in Q4 2022.
  • Macquarie Group opened 35 new positions and closed 525 in Q4 2022.
  • Macquarie Group's portfolio value rose 3.9% quarter-over-quarter to $84.7B.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.